These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38531362)

  • 1. Monitoring spinal muscular atrophy with three-dimensional optoacoustic imaging.
    Nedoschill E; Wagner AL; Danko V; Buehler A; Raming R; Jüngert J; Neurath MF; Waldner MJ; Rother U; Woelfle J; Trollmann R; Knieling F; Regensburger AP
    Med; 2024 May; 5(5):469-478.e3. PubMed ID: 38531362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI patterns of muscle involvement in type 2 and 3 spinal muscular atrophy patients.
    Brogna C; Cristiano L; Verdolotti T; Pichiecchio A; Cinnante C; Sansone V; Sconfienza LM; Berardinelli A; Garibaldi M; Antonini G; Pane M; Pera MC; Antonaci L; Ficociello L; Albamonte E; Tasca G; Begliuomini C; Tartaglione T; Maggi L; Govoni A; Comi G; Colosimo C; Mercuri E
    J Neurol; 2020 Apr; 267(4):898-912. PubMed ID: 31776722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polysomnography findings and respiratory muscle function in infants with early onset spinal muscular atrophy after gene replacement as monotherapy: A prospective study.
    Barrois R; Griffon L; Barnerias C; Gitiaux C; Desguerre I; Fauroux B; Khirani S
    Sleep Med; 2024 Jul; 119():335-341. PubMed ID: 38749258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing pregnancy in a spinal muscular atrophy type III patient in Indonesia: a case report.
    Setyaningrum CTS; Harahap ISK; Nurputra DK; Rachman IT; Harahap NIF
    J Med Case Rep; 2022 Jan; 16(1):14. PubMed ID: 35033190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of muscle strength with a handheld dynamometer in patients with chronic spinal muscular atrophy.
    Febrer A; Rodriguez N; Alias L; Tizzano E
    J Rehabil Med; 2010 Mar; 42(3):228-31. PubMed ID: 20411217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial.
    Mercuri E; Muntoni F; Baranello G; Masson R; Boespflug-Tanguy O; Bruno C; Corti S; Daron A; Deconinck N; Servais L; Straub V; Ouyang H; Chand D; Tauscher-Wisniewski S; Mendonca N; Lavrov A;
    Lancet Neurol; 2021 Oct; 20(10):832-841. PubMed ID: 34536405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional and surgical treatments in patients with spinal muscular atrophy (SMA).
    Boulay C; Peltier E; Jouve JL; Pesenti S
    Arch Pediatr; 2020 Dec; 27(7S):7S35-7S39. PubMed ID: 33357596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characterizations of three adults with genetically confirmed spinal muscular atrophy: a case series.
    Setyaningrum CTS; Harahap ISK; Nurputra DK; Ar Rochmah M; Sadewa AH; Alkarani GH; Harahap NIF
    J Med Case Rep; 2022 Nov; 16(1):435. PubMed ID: 36376972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and genetic study of spinal muscular atrophies in Oman.
    Koul R; Al Futaisi A; Chacko A; Rao V; Simsek M; Muralitharan S; Ganguly SS; Bayoumi R
    J Child Neurol; 2007 Oct; 22(10):1227-30. PubMed ID: 17940251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial.
    Day JW; Finkel RS; Chiriboga CA; Connolly AM; Crawford TO; Darras BT; Iannaccone ST; Kuntz NL; Peña LDM; Shieh PB; Smith EC; Kwon JM; Zaidman CM; Schultz M; Feltner DE; Tauscher-Wisniewski S; Ouyang H; Chand DH; Sproule DM; Macek TA; Mendell JR
    Lancet Neurol; 2021 Apr; 20(4):284-293. PubMed ID: 33743238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid reflected-ultrasound computed tomography versus B-mode-ultrasound for muscle scoring in spinal muscular atrophy.
    Danko V; Jüngert J; Schuessler S; Buehler A; Klett D; Federle A; Roos A; Lochmüller H; Neurath MF; Woelfle J; Trollmann R; Waldner MJ; Knieling F; Regensburger AP; Wagner AL
    J Neuroimaging; 2023; 33(3):393-403. PubMed ID: 36627228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synaptic defects in type I spinal muscular atrophy in human development.
    Martínez-Hernández R; Bernal S; Also-Rallo E; Alías L; Barceló MJ; Hereu M; Esquerda JE; Tizzano EF
    J Pathol; 2013 Jan; 229(1):49-61. PubMed ID: 22847626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal muscular atrophy in Ghanaian children confirmed by molecular genetic testing: a case series.
    Hammond CK; Oppong E; Ameyaw E; Dogbe JA
    Pan Afr Med J; 2023; 46():78. PubMed ID: 38282771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac function evaluation in children with spinal muscular atrophy: A case-control study.
    He X; Li X; Yan M; Peng H; Zhang L; Liang Y; Tang W; Li S
    Pediatr Int; 2024; 66(1):e15769. PubMed ID: 38742693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle strength and motor function throughout life in a cross-sectional cohort of 180 patients with spinal muscular atrophy types 1c-4.
    Wadman RI; Wijngaarde CA; Stam M; Bartels B; Otto LAM; Lemmink HH; Schoenmakers MAGC; Cuppen I; van den Berg LH; van der Pol WL
    Eur J Neurol; 2018 Mar; 25(3):512-518. PubMed ID: 29194869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observational study of spinal muscular atrophy type 2 and 3: functional outcomes over 1 year.
    Kaufmann P; McDermott MP; Darras BT; Finkel R; Kang P; Oskoui M; Constantinescu A; Sproule DM; Foley AR; Yang M; Tawil R; Chung W; Martens B; Montes J; O'Hagen J; Dunaway S; Flickinger JM; Quigley J; Riley S; Glanzman AM; Benton M; Ryan PA; Irvine C; Annis CL; Butler H; Caracciolo J; Montgomery M; Marra J; Koo B; De Vivo DC; ;
    Arch Neurol; 2011 Jun; 68(6):779-86. PubMed ID: 21320981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and molecular insights into spinal muscular atrophy due to mutations in BICD2.
    Rossor AM; Oates EC; Salter HK; Liu Y; Murphy SM; Schule R; Gonzalez MA; Scoto M; Phadke R; Sewry CA; Houlden H; Jordanova A; Tournev I; Chamova T; Litvinenko I; Zuchner S; Herrmann DN; Blake J; Sowden JE; Acsadi G; Rodriguez ML; Menezes MP; Clarke NF; Auer Grumbach M; Bullock SL; Muntoni F; Reilly MM; North KN
    Brain; 2015 Feb; 138(Pt 2):293-310. PubMed ID: 25497877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study of 83 cases with spinal muscular atrophy in children].
    Li H; Wang HL; Shan CM
    Zhonghua Er Ke Za Zhi; 2004 Oct; 42(10):762-4. PubMed ID: 16221347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [SMA: from gene discovery to gene therapy].
    Barkats M
    Med Sci (Paris); 2020 Feb; 36(2):137-140. PubMed ID: 32129749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features of spinal muscular atrophy (SMA) type 2.
    Cancès C; Richelme C; Barnerias C; Espil C
    Arch Pediatr; 2020 Dec; 27(7S):7S18-7S22. PubMed ID: 33357592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.